What is the recommended initial dose of Tresiba (insulin degludec) when adding it to a patient's diabetic regimen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose of Tresiba (Insulin Degludec)

Yes, 10 units once daily is the recommended starting dose for insulin-naive patients with type 2 diabetes when adding Tresiba to their regimen. 1

FDA-Approved Starting Dose

The FDA label for insulin degludec explicitly states: "The recommended starting dose of Insulin Degludec in insulin naïve patients with type 2 diabetes mellitus is 10 units once daily." 1

This recommendation is consistently supported across multiple guideline societies including the American College of Physicians and American Diabetes Association, which endorse starting insulin-naive type 2 diabetes patients on 10 units or 0.1-0.2 units/kg body weight once daily. 2

Dosing Algorithm

Standard initiation approach:

  • Start with 10 units once daily at the same time each day 3, 2, 1
  • Continue metformin unless contraindicated 3
  • Consider reducing sulfonylurea dose by 50% if the patient is on one, to minimize hypoglycemia risk 4

Titration schedule:

  • Increase by 2 units every 3-4 days if fasting glucose is 140-179 mg/dL 3, 2, 1
  • Increase by 4 units every 3-4 days if fasting glucose is ≥180 mg/dL 3, 2
  • Target fasting plasma glucose of 80-130 mg/dL 3
  • If hypoglycemia occurs, reduce dose by 10-20% 3, 2

When to Consider Higher Starting Doses

For patients with severe hyperglycemia (HbA1c ≥9%, blood glucose ≥300-350 mg/dL, or symptomatic/catabolic features), consider starting with 0.3-0.4 units/kg/day rather than the standard 10 units. 3, 2 These patients may require immediate basal-bolus insulin therapy rather than basal insulin alone. 3

Critical Threshold to Recognize

Stop escalating basal insulin when the dose exceeds 0.5 units/kg/day. 3, 2 At this point, add prandial insulin (starting with 4 units before the largest meal or 10% of basal dose) rather than continuing to increase Tresiba, as further escalation leads to "overbasalization" with increased hypoglycemia risk and suboptimal control. 3

Monitoring Requirements

  • Daily fasting blood glucose monitoring is essential during titration 2
  • Reassess every 3 days during active titration 2
  • Check HbA1c every 3 months to assess overall glycemic control 4

Common Pitfalls to Avoid

  • Do not delay titration - adjust every 3-4 days as recommended, not weekly or monthly 3, 1
  • Do not discontinue metformin when adding insulin unless contraindicated 3
  • Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia with prandial insulin 3, 2
  • Do not mix or dilute Tresiba with any other insulin or solution 1

References

Guideline

Insulin Degludec Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Titration and Management for Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.